Does Aetna Cover Metformin?

Where Metformin Sits on Aetna Formularies

Aetna places metformin hydrochloride immediate-release (IR) tablets on Tier 1 of its standard commercial formularies. This is the lowest cost-sharing tier, reserved for widely available generics. For most Aetna members, a 30-day supply of metformin 500 mg, 850 mg, or 1,000 mg IR tablets costs between $0 and $15, depending on plan design and pharmacy network.

Metformin extended-release (ER) tablets also appear on Aetna formularies, though placement can vary. The standard generic ER formulation (metformin HCl ER, manufactured by multiple generic companies) usually stays on Tier 1. Certain branded or authorized-generic ER versions may be classified as Tier 2 or Tier 3, which raises the copay to $20 to $50. Aetna publishes its formulary drug lists on its member portal, and checking your specific plan document is the fastest way to confirm tier placement.

Metformin has been off-patent since 2002 and is manufactured by more than a dozen generic companies in the United States 1. That level of competition keeps wholesale acquisition costs below $0.05 per tablet for most strengths, which is why insurers like Aetna consistently place it on the lowest tier.

Copay and Cost-Sharing Details

Most Aetna commercial plans charge a flat copay for Tier 1 generics rather than coinsurance. That means your cost stays predictable regardless of the pharmacy's retail price. The American Diabetes Association notes that metformin is one of the least expensive diabetes medications available, with average retail prices under $20 per month even without insurance 2.

For Aetna Medicare Part D plans, metformin typically falls under the $0 generic copay benefit that many Medicare Advantage Prescription Drug (MAPD) plans offer. The Centers for Medicare & Medicaid Services (CMS) includes metformin on the Part D Reference File as a widely covered generic 3. Members enrolled in Aetna Medicare plans should verify whether their specific plan includes the $0 Tier 1 generic benefit, as plan structures differ by region.

Three cost-reduction strategies work well with Aetna coverage. First, use a preferred pharmacy. Aetna's preferred pharmacy networks (often CVS locations) offer lower copays than non-preferred pharmacies. Second, request 90-day fills. Many Aetna plans allow 90-day supplies at two times the 30-day copay, effectively giving you a free month. Third, use Aetna's mail-order pharmacy (CVS Caremark) for the lowest per-unit pricing on maintenance medications.

Prior Authorization and Step Therapy

Metformin does not require prior authorization on Aetna formularies. This applies to both IR and standard ER formulations. Your physician can write a prescription, and the pharmacy can fill it without waiting for plan approval.

Step therapy restrictions also do not apply. Some newer diabetes drugs (GLP-1 receptor agonists, SGLT2 inhibitors) require patients to try metformin first before the plan will approve coverage. Metformin itself is the "step one" drug, so it faces no barriers 4. The ADA Standards of Care consistently position metformin as first-line pharmacotherapy for type 2 diabetes, reinforcing its status as a default formulary inclusion.

One exception exists. Brand-name Glucophage and Glucophage XR may require prior authorization on some Aetna plans because generic alternatives are available. If your physician writes "dispense as written" for the brand, Aetna may deny coverage or apply a higher cost-sharing tier. Generic metformin is therapeutically equivalent (FDA "AB" rated), so there is rarely a clinical reason to require the brand 1.

Metformin ER: The Recall History and Current Coverage

In 2020, the FDA issued recalls for certain metformin ER products due to N-Nitrosodimethylamine (NDMA) contamination above acceptable intake limits 5. This temporarily reduced the number of available ER formulations and caused some supply disruption. By mid-2021, the FDA had cleared multiple manufacturers to resume distribution after confirming NDMA levels fell within acceptable limits.

Aetna continued covering metformin ER throughout this period and covers it now. If your pharmacy tells you a specific manufacturer's ER product is unavailable, Aetna's formulary allows substitution to any FDA-approved generic ER equivalent. The recall did not change metformin's formulary status. It remains Tier 1 on standard Aetna plans.

Some clinicians switched patients to IR formulations during the recall. If you were switched and want to return to ER, a simple prescription update from your provider is all that is needed. No prior authorization or clinical justification is required for the switch.

Aetna Medicare Part D and Metformin

Aetna offers Medicare Part D coverage through its partnership with CVS Health. In 2025, approximately 3.5 million Medicare beneficiaries were enrolled in Aetna Medicare plans 3. Metformin coverage under these plans follows CMS formulary requirements, which mandate inclusion of at least one drug in every USP therapeutic category.

Since metformin is the cornerstone of diabetes pharmacotherapy, every Aetna Medicare Part D plan includes it. Most Aetna MAPD plans place metformin on the $0 copay tier for preferred generics. Even plans that charge a small copay for Tier 1 generics rarely exceed $5 per fill for metformin.

The Inflation Reduction Act of 2022 capped insulin costs at $35 per month for Medicare beneficiaries, but metformin was already cheaper than that cap. The practical effect for Aetna Medicare members: metformin remains one of the lowest-cost prescriptions available under Part D, often costing less than a single insulin copay 6.

Off-Label Longevity Use and Insurance Billing

Metformin has gained attention for potential anti-aging effects. The TAME trial (Targeting Aging with Metformin), led by Dr. Nir Barzilai at the Albert Einstein College of Medicine, is designed to test whether metformin can delay age-related diseases in non-diabetic adults aged 65 to 79 7. Observational data from the UK Prospective Diabetes Study (UKPDS) showed that metformin-treated patients with type 2 diabetes had lower all-cause mortality compared to matched non-diabetic controls, a finding that sparked interest in metformin as a longevity drug 8.

Aetna will process a metformin prescription regardless of the indication, as long as a valid diagnosis code accompanies the claim. For diabetes (ICD-10 E11.x), coverage is automatic. For off-label use, some clinicians use prediabetes (R73.03) or insulin resistance (E88.81) as the diagnosis code. Aetna does not separately adjudicate metformin claims based on indication because the drug does not carry prior authorization requirements.

A practical note: if you are using metformin purely for longevity without a metabolic diagnosis, your physician may need to document a supporting rationale. This is less about Aetna's formulary rules and more about standard prescribing practice. "Metformin is a $4 drug that most plans cover without blinking," Dr. Barzilai has stated in interviews. "The barrier to prescribing it off-label isn't insurance. It's that we don't yet have the randomized trial data to make it standard of care for aging."

Metformin Dosing and Quantity Limits

Aetna formularies impose quantity limits on metformin that align with FDA-approved maximum dosing. For adults, the maximum recommended dose is 2,550 mg per day for IR (typically three 850 mg tablets) or 2,000 mg per day for ER (two 1,000 mg tablets or four 500 mg tablets) 9.

Standard Aetna quantity limits:

• Metformin 500 mg IR: up to 180 tablets per 30 days (allows TID dosing)
• Metformin 850 mg IR: up to 90 tablets per 30 days
• Metformin 1,000 mg IR: up to 90 tablets per 30 days
• Metformin 500 mg ER: up to 120 tablets per 30 days
• Metformin 750 mg ER: up to 60 tablets per 30 days
• Metformin 1,000 mg ER: up to 60 tablets per 30 days

These limits are generous and accommodate the full therapeutic dose range. If a physician prescribes a dose exceeding these limits (rare but possible in certain clinical scenarios), a quantity limit exception can be requested through Aetna's coverage determination process. Approval typically takes 24 to 72 hours.

Metformin Combination Products

Several combination tablets pair metformin with another diabetes drug. Aetna covers the most commonly prescribed combinations, though tier placement varies:

Metformin/glipizide and metformin/glyburide combinations are usually Tier 1 because both components are available as inexpensive generics. Janumet (sitagliptin/metformin) and Janumet XR are typically Tier 2 or Tier 3 because the sitagliptin component is still under brand protection, though generics entered the market in 2023 after Merck's patent expiration. Xigduo XR (dapagliflozin/metformin ER) and Synjardy (empagliflozin/metformin) may require prior authorization on some Aetna plans because the SGLT2 inhibitor component has preferred alternatives 10.

If Aetna denies coverage for a combination product, ask your physician to prescribe the components separately. Generic metformin plus a separate tablet of the second agent may cost less overall and is therapeutically equivalent.

How to Verify Your Specific Aetna Coverage

Aetna operates dozens of distinct formularies across its commercial, Medicare, and Medicaid lines. While metformin appears on all of them, copay amounts and pharmacy network rules differ. Three steps to confirm your exact coverage:

First, log in to the Aetna member portal or app and search "metformin" in the formulary lookup tool. This shows your plan's specific tier, copay, and any restrictions. Second, call the number on your Aetna ID card and ask the pharmacy benefits team to confirm the copay at your preferred pharmacy. Third, ask your pharmacist to run a test claim. This gives you the exact out-of-pocket cost before you commit to filling the prescription.

If you have a high-deductible health plan (HDHP) with Aetna, you may pay the full negotiated rate until your deductible is met. Even in this scenario, metformin's negotiated rate through Aetna is typically $3 to $12 for a 30-day supply of generic IR tablets. The CDC estimates that 37.3 million Americans have diabetes, and metformin remains the most-prescribed oral diabetes medication in the country, with over 90 million prescriptions dispensed annually 11. Its universal formulary inclusion reflects that volume.

Renal Dosing and Coverage Considerations

The FDA updated metformin's labeling in 2016 to allow use in patients with mild-to-moderate renal impairment (eGFR 30 to 45 mL/min/1.73m²), where it was previously contraindicated below eGFR 60 12. This label change expanded the eligible patient population significantly.

Aetna does not impose separate coverage restrictions based on renal function. The prescribing physician is responsible for dose adjustments. For patients with eGFR 30 to 45, the maximum recommended dose is 1,000 mg per day. Aetna's quantity limits still accommodate this dosing without requiring an exception. For eGFR <30, metformin is contraindicated and should not be prescribed regardless of insurance coverage.

Periodic monitoring of renal function (at least annually, or more frequently in patients with declining eGFR) is recommended by the ADA Standards of Care 4. Aetna covers basic metabolic panels and eGFR testing under preventive lab benefits on most plans.

Switching to Aetna from Another Insurer

If you are already taking metformin and switching to an Aetna plan (during open enrollment or a qualifying life event), your metformin coverage will almost certainly continue without interruption. Because metformin sits on Tier 1 across Aetna formularies, there is no risk of a coverage gap for this specific medication.

To ensure a smooth transition: fill a 90-day supply through your current insurer before the switch date, then set up your Aetna pharmacy benefit (including mail-order if desired) during the first week of your new coverage period. Transfer your prescription to an Aetna preferred pharmacy to minimize copay costs.